New hope for rare blood cancer: aggressive combo therapy shows promise
NCT ID NCT02858999
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 34 times
Summary
This study tested a powerful treatment plan for people under 70 with primary plasma cell leukemia, a rare and aggressive blood cancer. The approach combined several chemotherapy drugs followed by one or two stem cell transplants (using the patient's own cells or a donor's) and then maintenance therapy. The goal was to control the disease and improve how long patients live without the cancer coming back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AP-HP
Paris, 75004, France
-
CH Dunkerque
Dunkirk, 59385, France
-
CH Pays d'Aix
Aix-en-Provence, 13616, France
-
CHRU Lille
Lille, 59037, France
-
CHU Amiens
Amiens, 80054, France
-
CHU Besançon
Besançon, 25030, France
-
CHU Caen
Caen, 14033, France
-
CHU Clermont Ferrand
Clermont-Ferrand, 63003, France
-
CHU Dijon
Dijon, 21034, France
-
CHU Nancy
Nancy, 54035, France
-
CHU Nantes
Nantes, 44093, France
-
CHU Nice
Nice, 06003, France
-
CHU Poitiers
Poitiers, 86021, France
-
CHU Rennes
Rennes, 35033, France
-
CHU Strasbourg
Strasbourg, 67091, France
-
CHU Toulouse
Toulouse, 31059, France
-
CHU Tours
Tours, 37044, France
-
Hospices Civils de Lyon
Lyon, 69229, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.